Help | RSS Feed



Assembly Biosciences, Inc. (NASD:ASMB) Seasonal Chart

Assembly Biosciences, Inc. (NASD:ASMB) Seasonality

ASMB Relative to the S&P 500
ASMB Relative to the S&P 500

ASMB Relative to the Sector
ASMB Relative to the Sector

Monthly Seasonal Assembly Biosciences, Inc. (NASD:ASMB)

Seasonal Chart Analysis

Analysis of the Assembly Biosciences, Inc. (NASD:ASMB) seasonal charts above shows that a Buy Date of November 13 and a Sell Date of February 11 has resulted in a geometric average return of 9.64% above the benchmark rate of the S&P 500 Total Return Index over the past 6 years. This seasonal timeframe has shown positive results compared to the benchmark in 5 of those periods. This is a very good rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 6 years by an average of 21.15% per year.

The seasonal timeframe correlates Poorly with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

A word of caution: Only 6 years of data is available for shares of ASMB, perhaps insufficient to create a seasonal profile that accurately gauges the seasonal tendencies influencing the investment. Ideally, while 20 years is preferred, at least 10 years of data is required to perform a seasonal analysis that is considered to be reliable for future seasonal periods.

Assembly Biosciences Inc is a clinical stage biotechnology company advancing two innovative platform programs, a new class of oral therapeutics for the treatment of hepatitis B virus infection and novel class of oral synthetic live biotherapeutics.

Stocks mentioned in this post:

    Search Seasonal Charts by Symbol, Company, or Term

   Symbols by Letter: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z


Sponsored By...